Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Liquidia Technologies Inc
LQDACurrent price
13.72 USD
+0.04 USD (+0.29%)
Last closed
12.43 USD
Company
www.liquidia.com
ISIN
US53635D2027
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 170 295 424 USD
Yield for 12 month
+4.10 %
1Y
3Y
5Y
10Y
15Y
LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina. Address: 419 Davis Drive, Morrisville, NC, United States, 27560
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
26.78 USDP/E ratio
–Dividend Yield
–Current Year
+13 996 000 USD
Last Year
+17 488 000 USD
Current Quarter
+2 917 000 USD
Last Quarter
+4 448 000 USD
Current Year
+8 117 000 USD
Last Year
+14 600 000 USD
Current Quarter
+1 563 000 USD
Last Quarter
+2 883 000 USD
Key Figures LQDA
1 year
3 years
5 years
10 years
EBITDA
-119 697 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-43.49 %
PEG Ratio
–
Return On Equity TTM
-209.35 %
Wall Street Target Price
26.78 USD
Revenue TTM
13 996 000 USD
Book Value
0.91 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-35.60 %
Dividend Yield
–
Gross Profit TTM
8 117 000 USD
Earnings per share
-1.66 USD
Diluted Eps TTM
-1.66 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LQDA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History LQDA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation LQDA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
79.75
Price Sales TTM
83.62
Enterprise Value EBITDA
-9.43
Price Book MRQ
15.14
Financials LQDA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LQDA
For 52 weeks
8.26 USD
16.81 USD
50 Day MA
14.84 USD
Shares Short Prior Month
12 071 437
200 Day MA
12.18 USD
Short Ratio
13.13
Shares Short
12 534 841
Short Percent
22.52 %
BeatStart